Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-000961-19Phase 4Completed
Phase 4, randomised, double-blind trial of remifentanil and propofol (3 arms), sponsored by Helse Fonna. Primary endpoints: Relative change in systolic blood pressure, Relative change in heart rate and 1 more. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-000961-19.